Lv1
30 积分 2023-09-07 加入
Pharmaco-microdynamics (PMD): Redefining dose, exposure, and control for living drug carriers
6天前
已关闭
CD40 Agonist on Patient-Derived Xenograft Mice for the Treatment of B-Cell Acute Lymphoblastic Leukemia
7天前
已完结
Development of a Tumor-Specific Multivalent CD40 Agonist Antibody FAPxCD40 for Cancer Therapy: Balancing Efficacy and Toxicity
9天前
已完结
Tumour immunology: A close-range dual hit for tumour immunity
10天前
已完结
ILT2 and ILT4 Drive Myeloid Suppression via Both Overlapping and Distinct Mechanisms
26天前
已完结
The E. coli α-hemolysin secretion system and its use in vaccine development
1个月前
已完结
Specific loading of oncolytic VSV on CAR enhances CAR-T cell signaling and antitumor activity
1个月前
已完结
Exploiting pathogenic Escherichia coli to model transmembrane receptor signalling
1个月前
已完结
Extracellular accumulation of recombinant proteins fused to the carrier protein YebF in Escherichia coli
2个月前
已完结
Programmable engineered bacteria manipulate metabolism and remodel the TME in situ for enhancing adoptive cell therapy
2个月前
已完结
皖公网安备34019202002308
